Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 401–500 of 1,001
GABAA Receptor α Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment
Vinkers, C. H., van Oorschot, R., Nielsen, E. Ø., Cook, J. M., Hansen, H. H., Groenink, L., Olivier, B., & Mirza, N. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043054 · Cited by 55
Paul, J., Yévenes, G. E., Benke, D., Lio, A. D., Ralvenius, W. T., Witschi, R., Scheurer, L., Cook, J. M., Rudolph, U., Fritschy, J.-M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.221 · Cited by 47
Self-citationInterneuronal GABAA receptors inside and outside of synapses
Ferando, I., & Módy, I. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.001 · Cited by 54
McKay, P. F., Foster, K. L., Mason, D., McCane, S., He, X., June, H. L., Cook, J. M., Cummings, R., García, M., Williams, L. S., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1671-z · Cited by 54
Hypnotic Medications: Mechanisms of Action and Pharmacologic Effects
Mendelson, W. B. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50043-4 · Cited by 54
Palagini, L., & Bianchini, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.893015 · Cited by 53
Wen, Y., Dong, Z., Liu, J., Axerio-Cilies, P., Du, Y., Li, J., Chen, L., Zhang, L., Liu, L., Lu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01148-y · Cited by 53
Rupprecht, R., Pradhan, A. K., Kufner, M., Brunner, L.-M., Nothdurfter, C., Wein, S., Schwarzbach, J. V., Puig-Bosch, X., Rupprecht, C., & Rammes, G. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01532-3 · Cited by 53
Ubiquitin-proteasome dependent degradation of GABAAα1 in autism spectrum disorder
Crider, A., Pandya, C. D., Peter, D., Ahmed, A. O., & Pillai, A. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-45 · Cited by 53
Fitzgerald, A. C., Wright, B. T., & Heldt, S. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3457-x · Cited by 53
Kavvadias, D., Abou-Mandour, A. A., Czygan, F.-C., Beckmann, H., Sand, P. G., Riederer, P. F., & Schreier, P. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2283 · Cited by 53
Bailey, J., Papadopoulos, A., Seddon, K., & Nutt, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089603 · Cited by 53
Poe, M. M., Methuku, K. R., Li, G., Verma, A. R., Teske, K. A., Stafford, D. C., Arnold, L. A., Cramer, J. W., Jones, T. M., Cerne, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01332 · Cited by 53
Owen, R. M., Blakemore, D. C., Cao, L., Flanagan, N. J., Fish, R. L., Gibson, K. R., Gurrell, R., Huh, C. W., Kammonen, J., Mortimer‐Cassen, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00322 · Cited by 53
Atack, J. R. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57004-9 · Cited by 52
Ginns, E. I. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.t01-1-102082.x · Cited by 52
Zhang, L., Guo, H., Zhang, H., Xu, T., He, B., Wang, Z., Yang, Y., Tang, X.-D., Zhang, P., & Liu, F. (2017) · Europe PMC (PubMed Central) · Cited by 52
Puberty, steroids and GABAA receptor plasticity
Smith, S. S., Aoki, C. J., & Shen, H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.011 · Cited by 52
Russell, M. G. N., Carling, R. W., Street, L. J., Hallett, D. J., Goodacre, S. C., Mezzogori, E., Reader, M., Cook, S. M., Bromidge, F. A., Newman, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051200u · Cited by 52
Grigoriadis, D. E., Hoare, S. R. J., Lechner, S. M., Slee, D. H., & Williams, J. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.149 · Cited by 52
Zeller, A., Arras, M., Jurd, R., & Rudolph, U. (2007) · BMC Pharmacology · doi:10.1186/1471-2210-7-2 · Cited by 52
Self-citationWerner, D. F., Blednov, Y. A., Ariwodola, O. J., Silberman, Y., Logan, E., Berry, R. B., Borghese, C. M., Matthews, D. B., Weiner, J. L., Harrison, N. L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106161 · Cited by 52
Development of Subtype Selective GABAAModulators
Dawson, G. R., Collinson, N., & Atack, J. R. (2005) · CNS Spectrums · doi:10.1017/s1092852900009871 · Cited by 52
Grunwald, C., Rundfeldt, C., Lankau, H., Arnold, T. B., Höfgen, N., Dost, R., Egerland, U., Hofmann, H., & Unverferth, K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509400 · Cited by 51
Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies
González, L. A., Gatch, M. B., Taylor, C. M., Bell-Horner, C. L., Forster, M. J., & Dillon, G. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151142 · Cited by 51
GABAA receptor modulation: Potential to deliver novel pain medicines?
Munro, G., Hansen, R. B., & Mirza, N. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.070 · Cited by 50
Restoring the Spinal Pain Gate
Zeilhofer, H. U., Ralvenius, W. T., & Acuña, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.007 · Cited by 50
Neurochemistry and Molecular Neurobiology of Aggressive Behavior
Miczek, K. A., Faccidomo, S., Fish, E. W., & DeBold, J. F. (2006) · Springer eBooks · doi:10.1007/978-0-387-30405-2_7 · Cited by 50
Reynolds, L. M., Engin, E., Tantillo, G., Lau, H. M., Muschamp, J. W., Carlezon, W. A., & Rudolph, U. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.115 · Cited by 49
Self-citationMilić, M., Divljaković, J., Rallapalli, S., Linn, M. L. V., Stamenić, T. T., Cook, J. M., & Savić, M. M. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283512c85 · Cited by 49
The effects of anaesthetics and sedatives on brain inflammation
Dominguini, D., Steckert, A. V., Michels, M., Borges, M. S., Ritter, C., Barichello, T., Thompson, J. P., & Dal‐Pizzol, F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.009 · Cited by 49
The light spot test: Measuring anxiety in mice in an automated home-cage environment
Aarts, E., Maroteaux, G., Loos, M., Koopmans, B., Kovačević, J., Smit, A. B., Verhage, M., & van der Sluis, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.011 · Cited by 49
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., Cook, J. M., Yin, W., & Bokonjić, D. R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.07.013 · Cited by 49
Lim, R., Ellett, L. M. K., Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029221 · Cited by 48
Raol, Y. H., Zhang, G., Budreck, E. C., & Brooks‐Kayal, A. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.005 · Cited by 48
Fernández, S. P., Mewett, K. N., Hanrahan, J. R., Chebib, M., & Johnston, G. A. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.069 · Cited by 48
Follesa, P., Mancuso, L., Biggio, F., Mostallino, M. C., Manca, A., Mascia, M. P., Busonero, F., Talani, G., Sanna, E., & Biggio, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.896 · Cited by 48
Anxiolytics targeting GABA A receptors: Insights on etifoxine
Poisbeau, P., Gazzo, G., & Calvel, L. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468030 · Cited by 47
Milić, M., Stamenić, T. T., Joksimovic, S. M., Biawat, P., Rallapalli, S., Divljaković, J., Radulović, T., Cook, J. M., & Savić, M. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.016 · Cited by 47
GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone
Biggio, G., Follesa, P., Sanna, E., Purdy, R. H., & Concas, A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46064-8 · Cited by 47
Oxytocin enhances the inhibitory effects of diazepam in the rat central medial amygdala
Viviani, D., Terrettaz, T., Magara, F., & Stoop, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.039 · Cited by 46
Smith, S. S. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00135 · Cited by 46
Chapter 13 Synaptic and extrasynaptic GABAA receptor and gephyrin clusters
Christie, S. B., Li, R.-W., Miralles, C. P., Riquelme, R., Yang, B. Y., Charych, E. I., Yu, W., Daniels, S. B., Cantino, M. E., & Blas, A. L. D. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)36015-1 · Cited by 46
Mechanism of action of general anaesthetics — new information from molecular pharmacology
Thompson, S., & Wafford, K. A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00013-3 · Cited by 46
Neurosteroid modulation of recombinant and synaptic GABAA receptors
Lambert, J. J., Harney, S. C., Belelli, D., & Peters, J. A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46063-6 · Cited by 46
Rashid, M. U., Alamzeb, M., Ali, S., Ullah, Z., Shah, Z. A., Naz, I., & Khan, M. R. (2019) · Phytotherapy Research · doi:10.1002/ptr.6466 · Cited by 45
Limiting Activity at β1-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia
Gee, K. W., Tran, M. B., Hogenkamp, D. J., Johnstone, T. B. C., Bagnera, R. E., Yoshimura, R. F., Huang, J.-C., Belluzzi, J. D., & Whittemore, E. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161885 · Cited by 45
Molecular Pathways of Anxiety Revealed by Knockout Mice
Tóth, M., & Wood, S. J. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:101 · Cited by 45
Conformationally Constrained Anesthetic Steroids That Modulate GABAA Receptors
Anderson, A., Boyd, A. C., Clark, J. K., Fielding, L., Gemmell, D. K., Hamilton, N. M., Maidment, M. S., May, V., McGuire, R., McPhail, P., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000977e · Cited by 45
El‐Haj, B. M., Ahmed, S. B. M., Garawi, M. A., & Ali, H. S. (2018) · Molecules · doi:10.3390/molecules23092119 · Cited by 44
Emerging drug targets for pain treatment
Li, J., & Zhang, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.017 · Cited by 44
Voss, J., Sánchez, C., Michelsen, S., & Ebert, B. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.007 · Cited by 44
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1243-0 · Cited by 44
Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder
Lin, S.-K., Chen, C.-K., Ball, D., Liu, H.-C., & Loh, E.-W. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500203 · Cited by 44
Bailey, S., & Tóth, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-04.2004 · Cited by 44
Möhler, H., Rudolph, U., Boison, D., Singer, P., Feldon, J., & Yee, B. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.003 · Cited by 44
Self-citationPopik, P., Kostakis, E., Krawczyk, M., Nowak, G., Szewczyk, B., Krieter, P. A., Chen, Z., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107201 · Cited by 44
Pathophysiology and Pharmacology of GABAA Receptors
Möhler, H., Fritschy, J., Vogt, K. E., Crestani, F., & Rudolph, U. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_9 · Cited by 44
Self-citationThe Legacy of the Benzodiazepine Receptor
Möhler, H. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.008 · Cited by 43
Self-citationEthanol-Induced Plasticity of GABAA Receptors in the Basolateral Amygdala
Lindemeyer, A. K., Liang, J., Marty, V. N., Meyer, E. M., Suryanarayanan, A., Olsen, R. W., & Spigelman, I. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1297-z · Cited by 43
Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors
Ralvenius, W. T., Neumann, E., Pagani, M., Acuña, M. A., Wildner, H., Benke, D., Fischer, N., Rostaher, A., Schwager, S., Detmar, M. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05709-0 · Cited by 43
Self-citationOh, D.-R., Kim, Y., Jo, A., Choi, E. J., Oh, K.-N., Kim, J., Kang, H., Kim, Y. R., & Choi, C. Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.003 · Cited by 43
GABA(A) receptor-targeted drug development -New perspectives in perioperative anesthesia
Antkowiak, B., & Rammes, G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1599356 · Cited by 43
Schneider Gasser, E. M., Duveau, V., Prenosil, G. A., & Fritschy, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05558.x · Cited by 40
Self-citationOlsen, R. W. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1382-3 · Cited by 43
Karim, N., Gavande, N. S., Wellendorph, P., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.002 · Cited by 43
Vinkers, C. H., Mirza, N. R., Olivier, B., & Kahn, R. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.513382 · Cited by 43
Licata, S. C., Platt, D. M., Cook, J. M., Sarma, P., Griebel, G., & Rowlett, J. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081612 · Cited by 43
Heldt, S. A., & Ressler, K. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0693-10.2010 · Cited by 42
The learned safety paradigm as a mouse model for neuropsychiatric research
Pollak, D. D., Monje, F. J., & Lübec, G. (2010) · Nature Protocols · doi:10.1038/nprot.2010.64 · Cited by 42
GABA homeostasis contributes to the developmental programming of anxiety-related behavior
Depino, A. M., Tsetsenis, T., & Gross, C. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.006 · Cited by 42
The influence of stress at puberty on mood and learning: Role of the α4βδ GABAA receptor
Smith, S. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.065 · Cited by 42
Panhelainen, A. E., & Korpi, E. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.011 · Cited by 42
Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients
Obayashi, K., Araki, T., Nakamura, K., Kurabayashi, M., Nojima, Y., Hara, K., Nakamura, T., & Yamamoto, K. (2013) · Drugs in R&D · doi:10.1007/s40268-013-0019-3 · Cited by 42
Reynolds, D. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.015 · Cited by 42
Prescription Drugs Used in Insomnia
Dujardin, S., Pijpers, A., & Pevernagie, D. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.03.001 · Cited by 41
Ramirez, A. D., Gotter, A. L., Fox, S. V., Tannenbaum, P. L., Yao, L., Tye, S. J., McDonald, T. P., Brunner, J., Garson, S. L., Reiss, D. R., et al. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00254 · Cited by 41
Wheless, J. W., & Phelps, S. J. (2012) · Journal of Child Neurology · doi:10.1177/0883073812463609 · Cited by 41
Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei
Kang-Park, M.-H., Wilson, W. A., & Moore, S. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00340-x · Cited by 41
Diazepam Decreases Action Potential Firing of Neocortical Neurons via Two Distinct Mechanisms
Drexler, B., Zinser, S., Hentschke, H., & Antkowiak, B. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f9c035 · Cited by 41
Antkowiak, B., & Rudolph, U. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000358 · Cited by 41
Self-citationEngin, E., Bakhurin, K. I., Smith, K. S., Hines, R. M., Reynolds, L. M., Tang, W., Sprengel, R., Moss, S. J., & Rudolph, U. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.41 · Cited by 40
Self-citationMathiasen, L., Mirza, N. R., & Rodgers, R. J. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.014 · Cited by 40
Cortical Glutamatergic Neurons Mediate the Motor Sedative Action of Diazepam
Zeller, A., Crestani, F., Camenisch, I., Iwasato, T., Itohara, S., Fritschy, J., & Rudolph, U. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038828 · Cited by 40
Self-citationWerner, D. F., Swihart, A., Rau, V., Jia, F., Borghese, C. M., McCracken, M. L., Iyer, S. V., Fanselow, M. S., Oh, I., Sonner, J. M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170431 · Cited by 40
Rowlett, J. K., Cook, J. M., Duke, A. N., & Platt, D. M. (2005) · CNS Spectrums · doi:10.1017/s1092852900009895 · Cited by 40
Hall, B. J., Chebib, M., Hanrahan, J. R., & Johnston, G. A. R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.034 · Cited by 40
Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor β1 subunit
Huntsman, M. M., & Huguenard, J. R. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.106617 · Cited by 40
The Role of High-Potency Benzodiazepines in the Treatment of Panic Disorder
Susman, J., & Klee, B. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0101 · Cited by 39
Humulone Modulation of GABAA Receptors and Its Role in Hops Sleep-Promoting Activity
Benkherouf, A. Y., Eerola, K., Soini, S. L., & Uusi‐Oukari, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.594708 · Cited by 40
Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2022) · Epilepsia · doi:10.1111/epi.17376 · Cited by 39
Licata, S. C., Jensen, J. E., Penetar, D. M., Prescot, A. P., Lukas, S. E., & Renshaw, P. F. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1431-1 · Cited by 39
Li, J., Liu, Q.-T., Chen, Y., Liu, J., Shi, J.-L., Liu, Y., & Guo, J.-Y. (2016) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2016/6530364 · Cited by 40
Witkin, J. M., Smith, J. L., Ping, X., Gleason, S. D., Poe, M. M., Li, G., Jin, X., Hobbs, J., Schkeryantz, J. M., McDermott, J. S., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.006 · Cited by 39
Kanematsu, T., Takeuchi, H., Terunuma, M., & Hirata, M. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)25243-7 · Cited by 39
Mechanisms of anabolic androgenic steroid modulation of α1β3γ2L GABAA receptors
Yang, P. G., Jones, B., & Henderson, L. P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00155-7 · Cited by 39
Differential expression of GABAA receptor subunits in the distinct nuclei of the rat amygdala
Fujimura, J., Nagano, M., & Suzuki, H. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.03.013 · Cited by 40
Churn, S. B., Rana, A., Lee, K., Parsons, J. T., De Blas, A., & Delorenzo, R. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01032.x · Cited by 35
Burt, D. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00505-8 · Cited by 39
Mirza, N. R., & Nielsen, E. Ø. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094474 · Cited by 38
“Recent studies show that GABAA receptors containing a 1 subunit mediate diazepam’s locomotor depressant action (Rudolph et al., 1999; McKernan et al., 2000), whereas GABAA receptors containing an 2 subunit mediate diazepam-induced anxiolysis in the elevated plus maze and lightdark box (Low et al.,…”
Background
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.